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Introduction: End-stage renal disease (ESRD) is associated with an increased propensity for critical illness, but
whether ESRD is independently associated with a greater risk of death after major surgical procedures is unclear.
Methods: This was a retrospective analysis of prospectively collected data from all adult (>18 years) patients
admitted to a 50-bed surgical intensive care unit (ICU) between January 2004 and January 2009. ESRD was defined
as the need for chronic peritoneal dialysis or hemodialysis for at least 6 weeks prior to ICU admission. We used
multivariable logistic regression analysis and propensity-score matching to adjust for possible confounders.
Results: In total, 12,938 adult patients were admitted during the study period; 199 patients had ESRD at ICU
admission, giving a prevalence of 1.5%. Patients with ESRD were more likely to be male (72.9% versus 63.0%,
P = 0.004) and had higher severity scores, a higher incidence of diabetes mellitus and cirrhosis, and a lower
incidence of cancer at ICU admission than those without ESRD. Patients with ESRD were more likely to have any
type of organ failure at ICU admission and during the ICU stay. Patients with ESRD had higher ICU and hospital
mortality rates (23.1% and 31.2% versus 5.5% and 10.0%, respectively, P <0.001 pairwise) and longer ICU length of
stay (2 (1 to 7) versus 1 (1 to 3) days, P <0.001). In multivariable logistic regression analysis, ESRD was independently
associated with a greater risk of in-hospital death (odds ratio = 3.84, 95% confidence interval 2.68 to 5.5, P <0.001).
In 199 pairs of patients, hematologic and hepatic failures were more prevalent, ICU and hospital mortality rates were
higher (23.1% versus 15.1% and 31.2% versus 19.1%, P <0.05 pairwise), and ICU length of stay was longer (2 (1 to 7)
versus 1 (1 to 7) days, P <0.001) in patients with ESRD.
Conclusions: In this large cohort of surgical ICU patients, presence of ESRD at ICU admission was associated with
greater morbidity and mortality and independently associated with a greater risk of in-hospital death. Our data can
be useful in preoperative risk stratification.Introduction
The prevalence of chronic kidney disease is increasing
worldwide [1,2]. The progressive nature of this chronic
health problem and the ensuing end-stage renal disease
(ESRD) creates a considerable burden on global health-
care resources [3]. The annual incidence of ESRD has
doubled over the past decade to reach about 100 to 336
new patients per million population [3,4]. Patients with
ESRD have a high propensity for critical illness and
require intensive care unit (ICU) admission 25 times
more frequently than patients without ESRD [5,6]. The* Correspondence: yasser.sakr@med.uni-jena.de
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reproduction in any medium, provided the orprevalence of ERSD in ICU patients ranges between 1.3%
and 7.3% and its presence is associated with a higher
degree of morbidity and mortality in these patients [5,7,8].
Whether ESRD is associated per se with a higher risk
in critically ill patients, independent of the severity and
nature of the critical illness, remains unclear. In a large
cohort of patients admitted to 170 adult ICU patients in
England, Wales, and Northern Ireland, ESRD was associ-
ated with a higher risk of in-hospital death after adjusting
for possible confounders [7]. This result was not, however,
confirmed in a large database of ESRD patients admitted
to 11 Canadian ICUs [5]. However, these studies [5,7]
included mixed medical and surgical ICU patients, with
a high proportion of medical admissions. Data on the
possible impact of ESRD on outcome after major surgicald. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in preoperative risk stratification of surgical patients and
hence could improve clinical decision making in these
patients. It may also be interesting to identify the patterns
of non-renal organ dysfunction/failure and predictors
of poor outcome in ESRD patients admitted to the ICU
after major surgical procedures. The aims of our study
were, therefore, to test the hypothesis that ESRD is
independently associated with a higher risk of death
after major surgical procedures and to identify possible
risk factors for in-hospital death in these patients.
Materials and methods
The study was approved by the institutional review board
of Friedrich Schiller University Hospital (Jena, Germany).
Informed consent was waived because of the retrospective,
anonymous nature of the analysis. We included all adult
(>18 years old) patients admitted to our 50-bed surgical
ICU from January 2004 to January 2009. For patients
admitted to the ICU more than once, only the first
admission was considered.
Data collection
Data were collected from vital sign monitors, ventilators,
and infusion pumps and automatically recorded by a
patient data management system (Copra System GmbH,
Sasbachwalden, Germany). This system provides staff
with complete electronic documentation, order entry (for
example, medications), and direct access to laboratory
results. Documentation in our ICU is exclusively electronic.
Data recorded prospectively on admission include age,
gender, serum parameters, primary and secondary ad-
mission diagnoses, and surgical procedures. Primary
and secondary diagnoses are recorded by using codes
from the International Classification of Diseases-10.
The Simplified Acute Physiology Score II (SAPS II) [9]
was calculated on admission, and the Sequential Organ
Failure Assessment (SOFA) score [10] was calculated daily
by the physician in charge of the patient by using a special
sheet. A plausibility check of the automatically transmitted
data was performed by the attending physician before
calculating the final scores. In sedated patients, the
Glasgow Coma Scale prior to initiation of sedation was
considered. Hospital mortality and hospital discharge
dates were available for all patients from the electronic
hospital records.
Definitions
ESRD was defined as the need for chronic peritoneal
dialysis or hemodialysis for at least 6 weeks prior to the
time of admission to the ICU. In patients with ESRD
following acute renal failure, 3 months were required
to establish the diagnosis of ESRD. Diabetes mellitus
refers to types 1 and 2 diabetes mellitus. SOFAmax wasdefined as the maximum SOFA score recorded during
the ICU stay, and SOFA mean as the mean value during
the ICU stay [10].
Statistical analysis
Data were analyzed by using SPSS 13.0 for Windows
(SPSS Inc., Chicago, IL, USA) and SAS version 9.1.3
software (SAS Institute Inc., Cary, NC, USA). The
Kolmogorov-Smirnov test was used to verify the normality
of distribution of continuous variables. Non-parametric
tests of comparison were used for variables evaluated as
not being normally distributed. Difference testing between
groups was performed by using a Wilcoxon test, Mann-
Whitney U test, chi-square test, and Fisher’s exact test
as appropriate.
To define the possible factors associated with poor
outcome in the whole cohort we performed a multivari-
able logistic regression analysis, with in-hospital death
as the dependent variable. The variables considered for
this analysis were age, sex, SAPS II, SOFA subscores, type
of surgery, emergency admissions, and ESRD. Colinearity
between variables was excluded before modeling (R2 >0.6),
and none of the covariates was colinear. A Hosmer and
Lemeshow goodness-of-fit test was performed, and odds
ratios (ORs) with 95% confidence intervals (CIs) were
computed.
To identify the possible risk factors associated with
in-hospital death in patients with ESRD, we performed a
forward stepwise multivariable logistic regression analysis
with in-hospital death as the dependent variable. The
variables considered for this analysis were age, sex,
SAPS II, SOFA subscores, type of surgery, emergency
admissions, the etiology of ESRD, residual urine output
(≤500 mL/day and >500 mL/day), and the type of access
for dialysis (arterio-venous shunt, central venous catheter,
and peritoneal catheter). Covariates were entered in the
model (P <0.2 on a univariate basis) step-by-step and
retained in the model if the P value was less than 0.2
after multivariable adjustment.
Propensity scores [11] were obtained through logistic
regression of patient characteristics on ESRD status
(Additional file 1: Table S1). The propensity score was
calculated as the probability based on the final model.
A greedy matching technique was used to match indi-
vidual ESRD patients with those who did not have
ESRD, based on propensity scores. The best-matched
propensity score was five digits long. Once a match
was made, the control patient was removed from the
pool. This process was then repeated by using four-digit
matching, then three-digit matching, and so on. The
process proceeded sequentially to a single-digit match
on propensity score. Differences between matched pairs
were tested by using a paired t test, Wilcoxon test, and
McNemar X2 statistics, as appropriate.
Apel et al. Critical Care 2013, 17:R298 Page 3 of 8
http://ccforum.com/content/17/6/R298All statistics were two-tailed. A P value of less than 0.05
was considered to be significant. Continuous variables are
presented as mean ± standard deviation or median (25%
to 75% interquartile range) and categorical variables as
number and percentage, unless otherwise indicated.
Results
Characteristics of the study cohort
During the study period, 12,938 patients were admitted
to our surgical ICU (mean age = 62.5 years (standard
deviation 14.9), male = 63.2%). The characteristics of the
study groups on admission to the ICU are shown in
Table 1. The prevalence of ESRD on admission to the
ICU was 1.5% (n = 199). Diabetic (40.2%) and hypertensive
(23.6%) nephropathies were the most common causes
of ESRD, followed by inflammatory conditions (chronic
glomerulonephritis, interstitial nephritis, chronic pyelo-
nephritis, and nephritic syndrome: 16.5%), congenital
diseases (renal hypoplasia and polycystic kidney: 6.5%),
and neoplasm (4.0%). Among patients with ESRD, 117
(58.8%) were anuric, whereas 82 patients (41.2%) had
residual diuresis prior to ICU admission (≤ or >500 mL/
day in 40 and 42 patients, respectively). The predominant
mode of dialysis in patients with ESRD was hemodialysis
(98.0%); in 64.3% of cases, this was performed through




Age in years, mean ± SD 62.5 ± 14.9
Male, n (%) 8,176 (63.2)
Severity scores, mean ± SD
SAPS II 38.3 ± 18.6
SOFA 6.0 ± 3.9
SOFA (without renal points) 5.7 ± 3.6





Other surgerya 2,196 (16.9)
Comorbidities, n (%)
Diabetes mellitus 6,749 (52.2)
Arterial hypertension 2,785 (21.5)
Cancer 2,501 (19.3)
Heart failure 1,645 (12.7)
Cirrhosis 472 (3.6)
aRenal/urinary tract, obstetric/gynecologic, ear, nose, and throat, and maxillofacial s
Score II; SD, standard deviation; SOFA, Sequential Organ Failure Assessment.atrial catheter. Only four patients (2%) were treated by
peritoneal dialysis.
Patients with ESRD were more likely to be male (72.9%
vs. 63.0%, P = 0.004), had higher severity scores, and had a
greater incidence of diabetes mellitus and cirrhosis and
lower incidence of cancer on admission to the ICU than
those without ESRD (Table 1). Gastrointestinal surgery
was more common (29.6% vs. 21.4%, P <0.001) and
neurosurgical procedures less common (15.9% vs. 4.0%,
P <0.001) in patients with ESRD compared with those
without ESRD. Serum urea, serum creatinine, leukocyte
count, and serum potassium were higher whereas hema-
tocrit values, platelet counts, pH, serum bicarbonate, and
serum sodium levels were lower in patients with ESRD
than those without ESRD (Additional file 1: Table S2).
Morbidity and mortality
The most prevalent organ failures on admission to the ICU
and at any time during the ICU stay were cardiovascular
(46.2% and 49.5%) followed by central nervous system
(36.7% and 42.4%) and respiratory (24.1% and 30.9%)
failures. Patients with ESRD were more likely to have
any type of organ failure on admission to the ICU and
at any time during the ICU stay than those without
ESRD (Table 2). Notably, hematologic failure occurred
up to 4 times more often in patients with ESRD (21.6%e intensive care unit according to the presence of
ESRD No ESRD P value
(n = 199) (n = 12,739)
62.4 ± 13.1 62.5 ± 14.9 0.509
145 (72.9) 8,031 (63.0) 0.004
56.3 ± 20.5 38.0 ± 18.4 <0.001
10.6 ± 4.2 6.0 ± 3.8 <0.001
7.5 ± 4.2 5.6 ± 3.6 <0.001
84 (42.2) 5,325 (41.8) 0.145
59 (29.6) 2,721 (21.4) <0.001
8 (4.0) 2,022 (15.9) <0.001
9 (4.5) 514 (4.0) 0.229
39 (19.6) 2,157 (16.9) 0.001
148 (74.4) 6,601 (51.8) <0.001
47 (23.6) 2,738 (21.5) 0.469
19 (9.5) 2,482 (19.5) <0.001
33 (16.6) 1,612 (12.7) 0.099
19 (9.5) 453 (3.6) <0.001
urgeries. ESRD, end-stage renal disease; SAPS II, Simplified Acute Physiology
Table 2 Morbidity and mortality of the study group according to the presence of end-stage renal disease
All patients ESRD No ESRD P value
(n = 12,938) (n = 199) (n = 12,739)
Organ failure, n (%)
- On admission to the ICU
Cardiovascular 5,974 (46.2) 135 (67.8) 5,839 (45.8) <0.001
CNS 4,747 (36.7) 90 (45.2) 4,657 (36.6) 0.012
Respiratory 3,120 (24.1) 68 (34.2) 3,052 (24.0) 0.001
Renal 390 (3.0) 199 (100) 237 (1.9) <0.001
Hematologic 309 (2.4) 27 (13.6) 282 (2.2) <0.001
Hepatic 215 (1.7) 15 (7.5) 200 (1.6) <0.001
- At any time during ICU stay
Cardiovascular 6,407 (49.5) 144 (72.4) 6,263 (49.2) <0.001
CNS 5,489 (42.4) 112 (56.3) 5,377 (42.2) <0.001
Respiratory 3,992 (30.9) 88 (44.2) 3,904 (30.6) <0.001
Renal 630 (4.9) 199 (100) 431 (3.4) <0.001
Hematologic 618 (4.8) 43 (21.6) 575 (4.5) <0.001
Hepatic 405 (3.1) 24 (12.1) 381 (3.0) <0.001
SOFAmax scores, mean ± SD
SOFAmax 6.5 ± 4.3 11.5 ± 4.6 6.4 ± 4.2 <0.001
SOFAmax without renal points 5.7 ± 3.6 7.5 ± 4.2 5.6 ± 3.6 <0.001
ICU mortality, n (%) 746 (5.8) 46 (23.1) 700 (5.5) <0.001
Hospital mortality, n (%) 1,330 (10.3) 62 (31.2) 1,268 (10.0) <0.001
ICU LOS in days, median (IQR) 1 (1–3) 2 (1–7) 1 (1–3) <0.001
CNS, central nervous system; ESRD, end-stage renal disease; ICU, intensive care unit; IQR, interquartile range; LOS, length of stay; SD, standard deviation; SOFA,
Sequential Organ Failure Assessment; SOFAmax, maximum Sequential Organ Failure Assessment score recorded during the intensive care unit stay.
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SOFAmax with (11.5 ± 4.6 vs. 6.4 ± 4.2, P <0.001) or with-
out (7.5 ± 4.2 vs. 5.6 ± 3.6, P <0.001) renal points was
higher in patients with ESRD than in those without ESRD.
The overall ICU and hospital mortality rates were 5.8%
and 10.3%, respectively, and the median ICU length of stay
(LOS) was 1 day (interquartile range: 1–3 day). Patients
with ESRD had higher ICU and hospital mortality rates
(23.1% and 31.2% vs. 5.5% and 10%, respectively, P <0.001
pairwise) and longer ICU LOS (2 (1–7) vs. 1 (1–3) days,
P <0.001) than those without ESRD. The most common
causes of death in the ICU were sepsis-related multiorgan
failure (52.2%), bleeding complications (15.2%), cardio-
genic shock (13.0%), and electrolyte disturbances (10.9%).
Multivariable analysis and propensity score matching
In multivariable logistic regression analysis with hospital
mortality as the dependent variable, ESRD was independ-
ently associated with a greater risk of in-hospital death
(OR = 3.84, 95% CI: 2.68-5.5, P <0.001) after adjustment
for age, gender, comorbidities, SAPS II, type of surgery,
and SOFA subscores on admission to the ICU (Additional
file 1: Table S3).In 199 pairs of patients matched according to a propen-
sity score, age, sex, comorbid conditions, severity scores,
and non-renal organ failure on admission to the ICU were
similar between patients with and those without ESRD
(Table 3). The type of surgery prior to admission to the
ICU was similar between the matched groups apart from
a lower prevalence of neurosurgical procedures in patients
with ESRD than in those who did not have ESRD (4.0% vs.
14.6%, P <0.001). Although the prevalence of respiratory,
cardiovascular, and central nervous system organ failures
was similar between the matched groups throughout the
ICU stay, hematologic (21.6% vs. 11.6%, P = 0.015) and
hepatic (12.1% vs. 8.5%, P = 0.03) organ failures were more
prevalent in patients with ESRD than in their propensity
score-matched pairs (Table 4). ICU and hospital mortality
rates were higher (23.1% vs. 15.1% and 31.2% vs 19.1%,
respectively, P <0.05 pairwise) and ICU LOS was longer
(2 (1–7) vs. 1 (1–7) days, P <0.001) in patients with ESRD
compared with their propensity score-matched pairs.
Predictors of poor outcome in patients with ESRD
In a multivariable analysis in patients with ESRD (Additional
file 1: Table S4), the use of central venous catheters for
dialysis (OR: 3.30, 95% CI: 1.36-8.04, P = 0.009) and higher
Table 3 Characteristics of the propensity score-matched
groups on admission to the intensive care unit
ESRD No ESRD P value
(n = 199) (n = 199)
Age in years, mean ± SD 62.4 ± 13.1 61.4 ± 14.4 0.524
Male, n (%) 145 (72.9) 161 (80.9) 0.057
Severity scores, mean ± SD
SAPS II 41.95 ± 19.35 40.39 ± 17.22 0.422
SOFAa 7.47 ± 4.20 7.04 ± 3.52 0.458
Comorbidities, n (%)
Diabetes mellitus 148 (74.4) 141 (70.9) 0.431
Arterial hypertension 47 (23.6) 33 (16.6) 0.080
Heart failure 33 (16.6) 21 (10.6) 0.079
Cirrhosis 19 (9.5) 20 (10.1) 0.866
Cancer 19 (9.5) 23 (11.6) 0.514
Type of surgery on
admission day, n (%)
Cardiothoracic 84 (42.2) 83 (41.7) 0.919
Digestive 59 (29.6) 53 (26.6) 0.504
Neurosurgery 8 (4.0) 29 (14.6) <0.001
Trauma 9 (4.5) 8 (4.0) 0.804
Others 39 (19.6) 26 (13.1) 0.122
Organ failure, n (%)
Cardiovascular 135 (67.8) 126 (63.3) 0.342
CNS 90 (45.2) 76 (38.2) 0.155
Respiratory 68 (34.2) 55 (27.6) 0.158
Hematologic 27 (13.6) 15 (7.5) 0.050
Hepatic 15 (7.5) 9 (4.5) 0.206
aWithout renal points. CNS, central nervous system; ESRD, end-stage renal
disease; SAPS II, Simplified Acute Physiology Score II; SD, standard deviation;
SOFA, Sequential Organ Failure Assessment.
Table 4 Sequential Organ Failure Assessment scores and
organ failure during the intensive care unit stay, and
mortality rates in the propensity score-matched subgroups
ESRD No ESRD P
value(n = 199) (n = 199)
SOFAmax scores, mean ± SD
SOFAmax (with renal points) 11.45 ± 4.62 8.31 ± 4.41 <0.001
SOFAmax (without renal points) 8.61 ± 4.96 7.79 ± 4.13 0.166
Organ failure, n (%)
Renal 199 (100.0) 7 (3.5) <0.001
Cardiovascular 144 (72.4) 134 (67.3) 0.516
CNS 112 (56.3) 100 (50.3) 0.144
Respiratory 88 (44.2) 79 (39.7) 0.658
Hematologic 43 (21.6) 23 (11.6) 0.015
Hepatic 24 (12.1) 17 (8.5) 0.030
ICU LOS in days, median (IQR) 2 (1–7) 1 (1–7) <0.001
Hospital mortality, n (%) 62 (31.2) 38 (19.1) 0.006
ICU mortality, n (%) 46 (23.1) 30 (15.1) 0.041
CNS, central nervous system; ESRD, end-stage renal disease; ICU, intensive care
unit; IQR, interquartile range; LOS, length of stay; SD, standard deviation; SOFA,
Sequential Organ Failure Assessment; SOFAmax, maximum Sequential Organ
Failure Assessment score recorded during the intensive care unit stay.
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P = 0.022) were independently associated with an in-
creased risk of in-hospital death. Female sex, admission
after cardiac versus non-cardiac procedures, and residual
urinary output of greater than 500 mL versus anuria were
independently associated with a lower risk of in-hospital
death (Additional file 1: Table S4).
Discussion
The main findings of our study were that (1) ESRD was
associated with a high incidence of comorbidities and
high degree of severity of illness on admission to the ICU;
(2) patients with ESRD were more likely to have any
type of organ failure during the ICU stay than those
without ESRD, especially hematologic failure; (3) ESRD
was independently associated with a greater risk of
in-hospital death in multivariable analysis; (4) mortality
rates were higher, ICU LOS was longer, and hematologic
and hepatic organ failures were more prevalent in patientswith ESRD compared with propensity score-matched
pairs; and (5) the use of central venous vascular access
and higher hepatic SOFA subscores were independently
associated with increased risk of in-hospital death, whereas
female sex, admission after cardiac procedures, and residual
urinary output of greater than 500 mL versus anuria were
independently associated with decreased risk of in-hospital
death in patients with ESRD.
The prevalence of ESRD on admission to the ICU in
our study was 1.5%, which lies within the lower
spectrum of the prevalence rates reported in previous
studies that included mostly medical ICU patients [5,7,8].
Indeed, the presence of ESRD may have influenced the
decision to perform surgical procedures in our hospital,
especially those performed on an elective basis. For this
reason, in addition to the single-center nature of the
study, we cannot extrapolate these data to other cohorts.
As expected, we found that ESRD was associated with
a high incidence of comorbidities on admission to the
ICU. This can be explained by the contribution of these
comorbidities to the pathophysiology of ESRD, especially
diabetes mellitus, which is the most common cause of
ESRD in developed countries [3]. The higher prevalence
of liver cirrhosis in patients with ESRD compared with
others may be attributed to the high incidence of hepa-
titis C and D in these patients [11]. Male sex is also well
recognized as a risk factor for chronic kidney disease
[3,12,13], which explains the predominance of men
(72.9%) among the patients with ESRD in our study. In
addition, the most frequent underlying diseases were
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an alteration of vascular control. This association with a
vascular injury related to ESRD might have contributed
to the worth outcome in these patients.
In our study, organ failure occurred more frequently
in patients with ESRD than in those without ESRD.
Impaired renal function is a major risk factor for
cardiovascular morbidity and mortality [14]. Several
factors may contribute to the increased incidence of
cardio-respiratory dysfunction in patients with ESRD,
including left ventricular hypertrophy, rapid electrolyte
shifts during dialysis, QT dispersion, sympathetic over-
activity, and deposition of calcium-phosphate precipitants
within arteries [14,15]. Acute pulmonary infections, peri-
operative volume overload, excessive inter-dialytic weight
gain, and primary cardiac events may also contribute to
respiratory failure in patients with ESRD. The higher
prevalence of hepatic failure in our patients may be
explained by the higher incidence of liver cirrhosis in
these patients compared with those without ESRD. The
impairment of renal elimination of hypnotic and sedative
agents given perioperatively in patients with ESRD [14]
may explain the high occurrence of neurological failure in
these patients. Interestingly, we found that hematologic
failure occurred up to 4 times more frequently in patients
with ESRD than in those without. Patients on chronic
dialysis have abnormalities in the cellular and plasma
systems regulating blood homeostasis, which may be
caused by uremic plasma associated with exposure of
blood to the hemodialysis membranes and tubing causing
increased thrombotic and bleeding risks [16]. Platelet
dysfunction is a common occurrence in patients with
ESRD, as a result of intrinsic platelet abnormalities and
impaired platelet-vessel wall interaction, and is probably
responsible for the hemorrhagic tendencies in these
patients [16]. Recently, Darlington and colleagues [17]
reported that 42.9% of patients with ESRD had a functional
hypocoagulable state, using thromboelastography, com-
pared with 8.9% in the control group.
In our study, ESRD was independently associated with a
greater risk of in-hospital death after adjusting for possible
confounders. We were able to confirm this finding by
using two statistical techniques, namely, logistic regression
multivariable analysis and propensity score matching.
To the best of our knowledge, our study is the first to
investigate this issue in a purely surgical cohort of ICU
patients. Our data support the notion that ESRD per se
may contribute, independently of other comorbidities
and severity of illness, to the risk of in-hospital death
after major surgical procedures. Several small studies
[8,18-21] and two large multicenter studies [5,7] have
reported contradictory results, with some confirming
[6-8,18] and others [5,19-21] disputing the independent
association between ESRD and poor outcome from criticalillness. The discrepancy in the results of these studies may
be explained by differences in case mix and local practices.
Indeed, these studies included mixed populations of
medical and surgical ICU patients (65% to 73% non-
surgical). Nevertheless, our results are in agreement with
the results of a large multicenter study that included
270,972 adult ICU patients admitted to 170 ICUs in the
UK (56% non-surgical cases) and that reported that ESRD
was associated with a greater risk of in-hospital death
after adjusting for baseline characteristics, severity of
illness, and comorbidities [7]. Interestingly, these authors
[7] reported that the ESRD population had higher mortal-
ity rates with lower numbers of non-renal organ failures,
confirming the independent influence of ESRD on the
risk of death in these patients.
The poor outcome in patients with ESRD is probably
multifactorial. These patients likely lack physiological
reserve, as evident from the high severity of illness
and the associated comorbid conditions on admission
to the ICU. Patients with ESRD may also have disturbed
immunological responses, favoring infectious complications
[7]. Perioperative patient management, especially volume
administration, may also have contributed to the unfavor-
able outcome. The need for vascular access to provide
hemodialysis in the ICU postoperatively and the frequent
occurrence of electrolyte disturbances in patients with
ERDS are other risk factors that may have influenced
outcomes. The results of the propensity score matching
in our study provide more insight about the possible
mechanisms by which ESRD may influence outcome in
patients with ESRD. Although the 199 pairs were well
matched according to baseline characteristics, severity
of illness, type of surgery, and the frequency of individual
non-renal organ failures on admission to the ICU, patients
with ESRD had a higher prevalence of hematologic and
hepatic failures in the ICU. Hematologic failure occurred
almost twice as often in patients with ESRD as in their
propensity score-matched pairs. As discussed above,
hematologic disturbances in patients with ESRD may
be associated with an increased risk of both bleeding
and thrombosis [16], which may contribute to the
pathogenesis of multiorgan failure and poor outcome.
As we used SOFA subscores to assess organ dysfunc-
tion/failure, hematologic failure in our study refers to
thrombocytopenia. In a prospective cohort of 329 critically
ill patients, Vanderschueren and colleagues [22] found
that thrombocytopenia was a risk marker for mortality,
independent of and complementary to established severity
of disease indices, and that both a low nadir platelet count
and a large decrease in platelet count predicted a poor
outcome in these patients.
Several studies have reported risk factors associated
with poor outcome in patients with ESRD in various
settings, including age [5,7,23], higher severity scores
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[5-7,24], the need for mechanical ventilation [5,8], and
anemia [25,26]. Data on risk factors for death in ESRD
patients undergoing major surgical procedures are scanty.
But this information may be important in risk stratifi-
cation of patients prior to major surgical procedures.
Previous studies have reported that the extent of organ
dysfunction failure is associated with the risk of death in
ICU patients with ESRD [5,7]. In our study, we identified
hepatic SOFA subscores as being independently associated
with an increased risk of in-hospital death. The use of
central venous catheters for dialysis was also independ-
ently associated with an increased risk of in-hospital
death. This observation confirms the results of a Can-
adian cohort of 578 ICU patients with ESRD [6]. This
association may have been subject to a bias-by-indication
in which sicker patients may have been preferentially
dialyzed using central venous access in the ICU; never-
theless, central venous catheters may be associated with
additional risks related to catheter placement and risk
of infection in the ICU, which may explain, at least in
part, the possible association of central venous access
and mortality in these patients.
In agreement with the results of a previous study by
Shah and colleagues [23], we found that female sex was
associated with a more favorable outcome in patients with
ESRD than male sex. Sexual dimorphism in the immune
response has been correlated to differences in sex steroid
hormone concentrations [27-29]. These differences in
hormonal secretion may explain the improved survival of
critically ill women. We also found that residual urinary
output of greater than 500 mL was associated with a
decreased risk of in-hospital death in patients with ESRD.
This observation may be explained by the ability of kidney
in these patients to reduce volume overload, which is
known to be associated with deleterious effects on out-
come of renal failure in the ICU [30].
Our study has some limitations. First, our analysis
is retrospective in nature and our results are only
hypothesis-generating. A larger prospective observational
trial in surgical ICU patients or in specific subpopulations
is warranted to clarify this issue. Second, the multivariable
analysis does not take into account unmeasured variables
and cannot establish a cause-effect relation. The confound-
ing effect of unmeasured variables, such as perioperative
volume management, cannot be excluded. Nevertheless,
many relevant variables were considered in our analysis.
Third, we included a heterogeneous case mix of surgical
ICU patients and were not able to perform subgroup
analysis for the different surgical disciplines, because of
the relatively small number of patients with ERSD in
the subgroups. Finally, the results of our study cannot
be extrapolated to populations with other case mixes,
such as medical patients. The singe-center nature of thestudy may be another limiting factor that hinders the
extrapolation of data to other cohorts of surgical ICU
patients with a different case mix. This should be explored
in large-scale multicenter studies. Nonetheless, the absence
of major variability in clinical practice in single-center
studies, such as ours, may reduce the impact of the
possible confounding effect of variability in ICU and
hospital organizational issues that may be difficult to
adjust for in large-scale multicenter studies.Conclusions
In this single-center, large cohort of patients in the sur-
gical ICU, ESRD was associated with higher morbidity
and mortality. The presence of ESRD was independently
associated with a higher risk of in-hospital death. Our data
can be useful in preoperative risk stratification. Further
large multicenter studies are warranted to confirm whether
these data can be generalized to a wide range of patients
in the surgical ICU.Key messages
 Postoperative patients with end-stage renal disease
(ESRD) have a high incidence of comorbidities and a
high degree of severity of illness on admission to the
intensive care unit (ICU).
 These patients are more likely to have any type of
organ failure during the ICU stay than those
without ESRD, especially hematologic failure.
 ESRD was independently associated with a greater
risk of in-hospital death.
 The use of central venous vascular access and higher
hepatic Sequential Organ Failure Assessment
(SOFA) subscores were independently associated
with increased risk of in-hospital death, whereas
female sex, admission after cardiac procedures, and
residual urinary output of more than 500 mL versus
anuria were independently associated with decreased
risk of in-hospital death in patients with ESRD.Additional file
Additional file 1: Table S1. The multivariable model used to obtain the
propensity score. Table S2. Physiological, acid–base parameters, and
serum electrolytes according to the presence of end-stage renal disease
(ESRD). Table S3. Logistic regression analysis with hospital mortality as
the dependent variable in the whole population. Table S4. Summary of a
multivariable forward stepwise logistic regression analysis with in-hospital
death as the dependent variable.
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